A Comparison of Hip Extension and Nordic Hamstring Exercise Programmes on Isokinetic Hamstring Strength

NCT03697473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2018-10-05

No results posted yet for this study

Summary

This study aimed to compare the effect of two hamstring strengthening programmes on hamstring muscle strength in Gaelic footballers. 26 Gaelic footballers were recruited and randomly assigned to one of two 4-week hamstring strengthening programmes, namely the hip extension exercise programme and the Nordic hamstring exercise protocol. Isokinetic hamstring and quadriceps strength were measured before and after the intervention.

Conditions

  • Hamstring Injury

Interventions

OTHER

Nordic hamstring exercise

The exercise protocol consisted of the following sets and repetitions Week 1 - 2 sessions with 2 sets of 6 repetitions. Week 2 - 2 sessions with 3 sets of 6 repetitions Week 3 - 2 sessions with 4 sets of 8 repetitions. Week 4 - 2 sessions with 4 sets of 10 repetitions.

OTHER

Hip extension exercise

The exercise protocol consisted of the following sets and repetitions Week 1 - 2 sessions with 2 sets of 6 repetitions. Week 2 - 2 sessions with 3 sets of 6 repetitions Week 3 - 2 sessions with 4 sets of 8 repetitions. Week 4 - 2 sessions with 4 sets of 10 repetitions.

Sponsors & Collaborators

  • Dublin City University

    lead OTHER

Principal Investigators

  • Enda Whyte, PhD · Dublin City University

  • Siobhán O'Connor, PhD · Dublin City University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-05
Primary Completion
2017-04-30
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03697473 on ClinicalTrials.gov